OTC Markets OTCQB - Delayed Quote USD

PetVivo Holdings, Inc. (PETV)

0.6310

+0.0300

+(4.99%)

At close: May 2 at 3:19:44 PM EDT

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. John Lai	CEO, President & Director	353.91k	--	1962
Mr. Garry N. Lowenthal	Chief Financial Officer	32.78k	--	1959
Mr. John F. Dolan	General Counsel, Chief Business Development Officer & Secretary	40.25k	--	1965
Ms. April Boyce	Vice President of Sales & Marketing	--	--	--
Mr. Michael Eldred BA, MBA	Commercialization & Operations Advisor and Executive Director	--	--	1970

5151 Edina Industrial Boulevard

Suite 575

Edina, MN 55439

United States

952 405 6216 https://www.petvivo.com

Sector:: Healthcare
Industry:
Full Time Employees:: 20

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

PetVivo Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

June 26, 2025 at 10:59 AM UTC - June 30, 2025 at 12:00 PM UTC

PetVivo Holdings, Inc. Earnings Date

April 8, 2025 at 12:00 AM UTC